133 related articles for article (PubMed ID: 3651838)
41. Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats.
Wright JW; Sullivan MJ; Harding JW
Neurosci Lett; 1985 Nov; 61(3):351-6. PubMed ID: 3001599
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of spontaneous and dopamine-inhibited prolactin release from anterior pituitary reaggregate cell cultures by angiotensin peptides.
Schramme C; Denef C
Life Sci; 1984 Apr; 34(17):1651-8. PubMed ID: 6374346
[TBL] [Abstract][Full Text] [Related]
43. Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides.
Shimamura M; Hazato T; Iwaguchi T
J Biochem; 1991 Mar; 109(3):492-7. PubMed ID: 1679058
[TBL] [Abstract][Full Text] [Related]
44. Participation of AT1 and AT2 receptor subtypes in the tonic inhibitory modulation of baroreceptor reflex response by endogenous angiotensins at the nucleus tractus solitarii in the rat.
Luoh HF; Chan SH
Brain Res; 1998 Jan; 782(1-2):73-82. PubMed ID: 9519251
[TBL] [Abstract][Full Text] [Related]
45. Effects of dipeptide bestatin on Porphyromonas gingivalis and epithelial cells.
Labbé S; Grenier D; Plamondon P; Uitto VJ; Mayrand D
J Periodontol; 2001 Jun; 72(6):714-21. PubMed ID: 11453232
[TBL] [Abstract][Full Text] [Related]
46. Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats.
Fregly MJ; Rowland NE
Brain Res Bull; 1991 Jul; 27(1):97-100. PubMed ID: 1933441
[TBL] [Abstract][Full Text] [Related]
47. Identification and characterization of aminopeptidases from Aplysia californica.
Bawab W; Querido E; Crine P; DesGroseillers L
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
[TBL] [Abstract][Full Text] [Related]
48. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
Fujimoto M; Mihara S; Shigeri Y; Itazaki K
Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989
[TBL] [Abstract][Full Text] [Related]
49. Cerebroventricular infusion of angiotensin antagonist does not influence hypertensive response to blood-borne angiotensin II.
Bruner CA; Fink GD
Brain Res; 1985 Dec; 360(1-2):15-23. PubMed ID: 4075167
[TBL] [Abstract][Full Text] [Related]
50. Hypoalgesic action of bestatin analogues that inhibit central aminopeptidases, but not neutral endopeptidase.
Otero MJ; Iglesias T; Fuentes JA
Neuropeptides; 1993 Sep; 25(3):175-82. PubMed ID: 8247255
[TBL] [Abstract][Full Text] [Related]
51. Pressor action and dipsogenicity induced by angiotensin II and III in rats.
Wright JW; Morseth SL; Abhold RH; Harding JW
Am J Physiol; 1985 Nov; 249(5 Pt 2):R514-21. PubMed ID: 4061676
[TBL] [Abstract][Full Text] [Related]
52. Mode of action of bestatin and leupeptin to induce the accumulation of acid soluble peptides in rat liver in vivo and the properties of the accumulated peptides. The important role of bestatin- and leupeptin-sensitive proteases in the protein degradation pathway in vivo.
Takahashi S; Kato H; Takahashi A; Noguchi T; Naito H
Int J Biochem; 1987; 19(5):401-12. PubMed ID: 3595989
[TBL] [Abstract][Full Text] [Related]
53. Kinetic properties of placental aminopeptidase A: N-terminal degradation of angiotensin II.
Sakura H; Kobayashi H; Mizutani S; Sakura N; Hashimoto T; Kawashima Y
Biochem Int; 1983 May; 6(5):609-15. PubMed ID: 6679727
[TBL] [Abstract][Full Text] [Related]
54. Hypotensive effects of sarthran in normotensive and spontaneously hypertensive rat strains.
Murray CE; Harding JW; Wright JW
Pharmacol Biochem Behav; 1991 Aug; 39(4):1029-32. PubMed ID: 1763099
[TBL] [Abstract][Full Text] [Related]
55. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
Sekine K; Fujii H; Abe F; Nishikawa K
Int J Cancer; 2001 Nov; 94(4):485-91. PubMed ID: 11745433
[TBL] [Abstract][Full Text] [Related]
56. An opiate receptor-associated aminopeptidase that degrades enkephalins.
Hui KS; Gioannini T; Hui M; Simon EJ; Lajtha A
Neurochem Res; 1985 Aug; 10(8):1047-58. PubMed ID: 2997642
[TBL] [Abstract][Full Text] [Related]
57. Bestatin as an experimental tool in mammals.
Scornik OA; Botbol V
Curr Drug Metab; 2001 Mar; 2(1):67-85. PubMed ID: 11465152
[TBL] [Abstract][Full Text] [Related]
58. Tonic reduction in central alpha 2-adrenoceptor activity by endogenous angiotensin III in the rat.
Lee HC; Chan JY; Chan SH
Chin J Physiol; 1990; 33(4):367-83. PubMed ID: 1965797
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.
Tieku S; Hooper NM
Biochem Pharmacol; 1992 Nov; 44(9):1725-30. PubMed ID: 1360211
[TBL] [Abstract][Full Text] [Related]
60. Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis.
Kokje RJ; Wilson WL; Brown TE; Karamyan VT; Wright JW; Speth RC
Hypertension; 2007 Jun; 49(6):1328-35. PubMed ID: 17470719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
